Nasdaq - Delayed Quote USD

Virtus KAR Health Sciences P (AAAEX)

31.24
+0.14
+(0.45%)
At close: May 22 at 8:00:01 PM EDT

Performance Overview

Morningstar Return Rating --
YTD Return 6.18%
5y Average Return 0.00%
Number of Years Up 2
Number of Years Down 1
Best 1Y Total Return (May 9, 2024) 25.79%
Worst 1Y Total Return (May 9, 2024) --
Best 3Y Total Return 25.79%
Worst 3Y Total Return 4.66%

Trailing Returns (%) Vs. Benchmarks

Monthly Total Returns
AAAEX
Category
YTD
3.41%
7.95%
1-Month
-5.90%
4.81%
3-Month
1.41%
7.18%
1-Year
4.70%
30.16%
3-Year
3.07%
16.10%
5-Year
9.93%
15.71%
10-Year
9.90%
15.27%
Last Bull Market
25.99%
23.06%
Last Bear Market
-8.71%
-13.88%

Annual Total Return (%) History

Year
AAAEX
Category
2024
--
--
2023
2.95%
--
2022
-11.48%
--
2021
25.79%
--
2020
--
27.63%

Past Quarterly Returns

YearQ1Q2Q3Q4
2024 9.90% -- -- --
2023 0.25% 1.44% -5.95% 7.64%
2022 -4.10% -8.71% -9.31% 11.51%
2021 3.35% 10.32% 2.71% 7.41%
2020 7.31% -- -- --

Rank in Category (By Total Return)

YTD 20
1-Month 46
3-Month 23
1-Year 40
3-Year 26
5-Year 25

Load Adjusted Returns

1-Year 4.70%
3-Year 3.07%
5-Year 9.93%
10-Year 9.90%

Performance & Risk

YTD Return 6.18%
5y Average Return 0.00%
Rank in Category (ytd) 20
% Rank in Category (ytd) --
Beta (5Y Monthly) 0.88
Morningstar Risk Rating

Fund Overview

Category Health
Fund Family Virtus
Net Assets 144.35M
YTD Return 3.41%
Yield 0.00%
Morningstar Rating
Inception Date Dec 22, 2014

Fund Summary

The fund seeks to achieve its objective by normally investing at least 80% of its net assets (plus borrowings made for investment purposes) in health sciences-related companies. The portfolio manager considers health sciences-related companies to include companies that design, manufacture or sell products or services used for or in connection with healthcare, medicine or life sciences. The fund will invest primarily in common stocks and other equity securities.

Related Tickers